ARCHIVED: Protein ZMYND8 tied to suppression of prostate cancer tumor metastasis
Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at Â鶹ӳ» MD Anderson Cancer Center. The findings, resulting from cell line and mouse model studies, are published in the July 28 online issue of Molecular Cell.
¡°These findings are important as cancer metastasis is a complicated...
ARCHIVED: Genetic cause of 15 percent of colorectal cancer diagnoses identified
Up to 15 percent of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been...
ARCHIVED: MD Anderson, NASA and ILC Dover partner on Space Suit Art Project to increase childhood cancer awareness
Today, several of Space City¡¯s best-known institutions ¡ª Â鶹ӳ» MD Anderson Cancer Center, the National Aeronautics and Space...